Table 3 Multivariate analysis of different prognostic factors in 100 patients with LSC
From: Overexpression of p53R2 is associated with poor prognosis in lung sarcomatoid carcinoma
Variable | Hazards ratio | 95% CI | P value |
|---|---|---|---|
Tumor size (>4.5 cm vs. ≤4.5 cm) | 1.561 | 0.899–2.708 | 0.114 |
Clinical stage (III-IV vs. I-II) | 5.160 | 2.589–10.282 | 0.000 |
Expression of p53R2 (High vs. Low) | 3.217 | 1.675–6.180 | 0.000 |